Table: Daito - 9-MTH group results

Daito Pharmaceutical

10/04/2026 07:31

Apr 10 (Reuters)- 
             Daito Pharamaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Feb 28, 2026        Feb 28, 2025     May 31, 2026 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             36.73               36.61            51.00    
                 (+0.3 pct)          (+5.6 pct)       (+0.7 pct)  
  Operating          2.75                1.87             3.30    
                 (+47.2 pct)         (-39.8 pct)      (+26.0 pct) 
  Recurring          2.97                2.03             3.50    
                 (+46.2 pct)         (-34.9 pct)      (+29.4 pct) 
  Net                2.27                1.22             2.50    
                 (+86.2 pct)         (-48.0 pct)      (+31.0 pct) 
  EPS             76.53 yen           39.86 yen        84.38 yen  
  Ann Div                             70.00 yen        40.00 yen  
  -Q2 div         20.00 yen           35.00 yen                   
  -Q4 div                             35.00 yen        20.00 yen  
  
  NOTE - Daito Pharamaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4577.T